Log In
Sunday 20th May 2018

Plan to axe drug price fixing

21st April 2008

The government's intention to get rid of the Pharmaceutical Price Regulation Scheme (PPRS) would dramatically affect the healthcare communications industry, according to a prominent PR consultant.

Fleishman-Hillard director Claire Ashbridge-Thomlinson spoke at her agency's yearly healthcare industry debate. Ashbridge-Thomlinson  said: 'Fixed pricing will have implications for marketing spend and a huge impact on the PR and PA side. If pharma companies receive less money for their drugs in the UK, they will have less to spend on comms activity. PR and PA agencies need to be aware of this."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018